Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 16, 2025
Hematochemical hallmarks as markers of pulmonary TB severity: A multicenter cross-sectional studyFrancesco Di Gennaro, Giacomo Guido, Sergio Cotugno, et al.Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|September 2, 2025
Symptomatic (STB) and Asymptomatic (ATB) tuberculosis in Italy: Results from a multicenter retrospective studySergio Cotugno, Giacomo Guido, Francesco Di Gennaro, et al.The European Respiratory Journal|April 15, 2016
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.Infection|January 11, 2026
Sex disparities in tuberculosis outcomes: evidence from a multicenter Italian cohort (Italian South TB Network (ISTB-Net)Francesco Di Gennaro, Alessandro Cornelli, Giacomo Guido, et al.Emerging Infectious Diseases|September 12, 2020
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020Giovanni Battista Migliori, Pei Min Thong, Onno Akkerman, et al.The European Respiratory Journal|May 23, 2017
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studySergey E Borisov, Keertan Dheda, Martin Enwerem, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2021
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospitalAnnalisa Mondi, Patrizia Lorenzini, Concetta Castilletti, et al.Pageof 13